Published in Science on May 14, 1999
Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev (2010) 2.37
Engineering asymmetric vesicles. Proc Natl Acad Sci U S A (2003) 2.14
Near-infrared-emissive polymersomes: self-assembled soft matter for in vivo optical imaging. Proc Natl Acad Sci U S A (2005) 2.10
A new mechanism of model membrane fusion determined from Monte Carlo simulation. Biophys J (2003) 1.65
Self-assembling materials for therapeutic delivery. Acta Biomater (2008) 1.51
Autonomous movement of platinum-loaded stomatocytes. Nat Chem (2012) 1.47
Electro-deformation and poration of giant vesicles viewed with high temporal resolution. Biophys J (2004) 1.46
Field theoretic study of bilayer membrane fusion. I. Hemifusion mechanism. Biophys J (2004) 1.42
Polymerization-induced self-assembly of block copolymer nano-objects via RAFT aqueous dispersion polymerization. J Am Chem Soc (2014) 1.41
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. Cancer Res (2012) 1.38
Refined contour analysis of giant unilamellar vesicles. Eur Phys J E Soft Matter (2004) 1.36
The origins of stability of spontaneous vesicles. Proc Natl Acad Sci U S A (2001) 1.29
Supramolecular assemblies from amphiphilic homopolymers: Testing the scope. J Am Chem Soc (2006) 1.28
Elasticity and phase behavior of DPPC membrane modulated by cholesterol, ergosterol, and ethanol. Biophys J (2005) 1.27
Bioresorbable Vesicles Formed through Spontaneous Self-Assembly of Amphiphilic Poly(ethylene oxide)-block-polycaprolactone. Macromolecules (2006) 1.26
Biomimetic delivery with micro- and nanoparticles. Adv Mater (2012) 1.25
Emerging Applications of Polymersomes in Delivery: from Molecular Dynamics to Shrinkage of Tumors. Prog Polym Sci (2007) 1.25
Highly permeable polymeric membranes based on the incorporation of the functional water channel protein Aquaporin Z. Proc Natl Acad Sci U S A (2007) 1.23
Polymersome carriers: from self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm (2008) 1.21
Multiple lipid compartments slow vesicle contents release in lipases and serum. ACS Nano (2007) 1.16
Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer. Open Nanomed J (2011) 1.14
Entropy driven self-assembly of nonamphiphilic colloidal membranes. Proc Natl Acad Sci U S A (2010) 1.13
Field theoretic study of bilayer membrane fusion: II. Mechanism of a stalk-hole complex. Biophys J (2005) 1.13
Missing pieces in understanding the intracellular trafficking of polycation/DNA complexes. J Control Release (2009) 1.12
Controlling and switching the morphology of micellar nanoparticles with enzymes. J Am Chem Soc (2011) 1.11
Thermo-responsive diblock copolymer worm gels in non-polar solvents. J Am Chem Soc (2014) 1.10
Targeted delivery of therapeutics to endothelium. Cell Tissue Res (2008) 1.10
Polymersomes: a new multi-functional tool for cancer diagnosis and therapy. Methods (2008) 1.09
Biomaterials for nanoparticle vaccine delivery systems. Pharm Res (2014) 1.09
Paramagnetic porous polymersomes. Langmuir (2008) 1.09
The fusion of membranes and vesicles: pathway and energy barriers from dissipative particle dynamics. Biophys J (2009) 1.08
Enhanced fluorescence imaging of live cells by effective cytosolic delivery of probes. PLoS One (2010) 1.06
Design of amphiphilic protein maquettes: controlling assembly, membrane insertion, and cofactor interactions. Biochemistry (2005) 1.05
Leuko-polymersomes. Faraday Discuss (2008) 1.04
Chemically induced supramolecular reorganization of triblock copolymer assemblies: trapping of intermediate states via a shell-crosslinking methodology. Proc Natl Acad Sci U S A (2002) 1.04
Block liposomes from curvature-stabilizing lipids: connected nanotubes, -rods, or -spheres. Langmuir (2009) 1.02
Gel-assisted formation of giant unilamellar vesicles. Biophys J (2013) 1.02
Bursting of sensitive polymersomes induced by curling. Proc Natl Acad Sci U S A (2009) 1.00
Porous Polymersomes with Encapsulated Gd-labeled Dendrimers as Highly Efficient MRI Contrast Agents. Adv Funct Mater (2009) 1.00
Photoinitiated destruction of composite porphyrin-protein polymersomes. J Am Chem Soc (2009) 0.99
Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging. Curr Top Med Chem (2013) 0.99
Bursting bubbles and bilayers. Theranostics (2012) 0.97
Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int J Nanomedicine (2013) 0.97
Improved tumor targeting of polymer-based nanovesicles using polymer-lipid blends. Bioconjug Chem (2011) 0.96
Calculation of free energy barriers to the fusion of small vesicles. Biophys J (2007) 0.95
In vivo fluorescence imaging: a personal perspective. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.95
A Critical Appraisal of RAFT-Mediated Polymerization-Induced Self-Assembly. Macromolecules (2016) 0.95
Controlling Bulk Optical Properties of Emissive Polymersomes Through Intramembranous Polymer-Fluorophore Interactions. Chem Mater (2007) 0.94
Synthetic biomimetic membranes and their sensor applications. Sensors (Basel) (2012) 0.94
Self-assembly of tunable protein suprastructures from recombinant oleosin. Proc Natl Acad Sci U S A (2012) 0.93
Two-photon microscopy of oxygen: polymersomes as probe carrier vehicles. J Phys Chem B (2010) 0.93
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano (2014) 0.92
Interactions of a charged nanoparticle with a lipid membrane: implications for gene delivery. Biophys J (2011) 0.91
The effect of chain length on protein solubilization in polymer-based vesicles (polymersomes). Biophys J (2003) 0.91
Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 0.91
Modular synthesis of biodegradable diblock copolymers for designing functional polymersomes. J Am Chem Soc (2010) 0.90
Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. Int J Nanomedicine (2013) 0.90
Polymeric core-shell assemblies mediated by host-guest interactions: versatile nanocarriers for drug delivery. Angew Chem Int Ed Engl (2009) 0.90
Size and structure of spontaneously forming liposomes in lipid/PEG-lipid mixtures. Biophys J (2002) 0.90
Synthesis and self-assembly of RGD-functionalized PEO-PB amphiphiles. Biomacromolecules (2009) 0.90
Designing communicating colonies of biomimetic microcapsules. Proc Natl Acad Sci U S A (2010) 0.90
Behavior of giant vesicles with anchored DNA molecules. Biophys J (2007) 0.89
Pathways to dewetting in hydrophobic confinement. Proc Natl Acad Sci U S A (2015) 0.89
Engineering Polymersome Protocells. J Phys Chem Lett (2011) 0.89
Recent trends in the tuning of polymersomes' membrane properties. Eur Phys J E Soft Matter (2011) 0.88
Field theoretic study of bilayer membrane fusion III: membranes with leaves of different composition. Biophys J (2007) 0.88
Materials chemistry: Liposomes derived from molecular vases. Nature (2012) 0.88
Tunable leuko-polymersomes that adhere specifically to inflammatory markers. Langmuir (2010) 0.88
Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia. Adv Healthc Mater (2013) 0.88
Engineering nanomedicines for improved melanoma therapy: progress and promises. Nanomedicine (Lond) (2010) 0.85
Minimum energy path to membrane pore formation and rupture. Phys Rev Lett (2011) 0.85
Polymerization-induced self-assembly of galactose-functionalized biocompatible diblock copolymers for intracellular delivery. J Am Chem Soc (2013) 0.85
Self-assembly of amphiphilic Janus dendrimers into uniform onion-like dendrimersomes with predictable size and number of bilayers. Proc Natl Acad Sci U S A (2014) 0.84
Interactions of membrane-active peptides with thick, neutral, nonzwitterionic bilayers. J Phys Chem B (2005) 0.84
High-density reconstitution of functional water channels into vesicular and planar block copolymer membranes. J Am Chem Soc (2012) 0.84
Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin. Biomacromolecules (2014) 0.84
Wet nanoscale imaging and testing of polymersomes. Small (2011) 0.84
Engineering of the E. coli outer membrane protein FhuA to overcome the hydrophobic mismatch in thick polymeric membranes. J Nanobiotechnology (2011) 0.83
Loading of Silica Nanoparticles in Block Copolymer Vesicles during Polymerization-Induced Self-Assembly: Encapsulation Efficiency and Thermally Triggered Release. J Am Chem Soc (2015) 0.83
Stable and robust polymer nanotubes stretched from polymersomes. Proc Natl Acad Sci U S A (2006) 0.83
Internal structure of magnetic endosomes. Eur Phys J E Soft Matter (2007) 0.83
Dewetting-induced membrane formation by adhesion of amphiphile-laden interfaces. J Am Chem Soc (2011) 0.82
Benzaldehyde-functionalized polymer vesicles. ACS Nano (2009) 0.82
Effect of lactoferrin- and transferrin-conjugated polymersomes in brain targeting: in vitro and in vivo evaluations. Acta Pharmacol Sin (2010) 0.82
Enhancing protein stability by adsorption onto raftlike lipid domains. J Am Chem Soc (2009) 0.82
Polymersome magneto-valves for reversible capture and release of nanoparticles. Nat Commun (2014) 0.82
Phospholipid-polymer amphiphile hybrid assemblies and their interaction with macrophages. Biomicrofluidics (2015) 0.81
Polyaspartamide Vesicle induced by Metallic Nanoparticles. Soft Matter (2012) 0.80
Counterion-mediated pattern formation in membranes containing anionic lipids. Adv Colloid Interface Sci (2014) 0.80
Engineering protocells: prospects for self-assembly and nanoscale production-lines. Life (Basel) (2015) 0.80
OX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery ability. J Mater Sci Mater Med (2012) 0.80
Block liposomes vesicles of charged lipids with distinctly shaped nanoscale sphere-, pear-, tube-, or rod-segments. Methods Enzymol (2009) 0.80
Influence of thermally driven surface undulations on tethers formed from bilayer membranes. Biophys J (2006) 0.80
Dynamic domains in polymersomes: mixtures of polyanionic and neutral diblocks respond more rapidly to changes in calcium than to pH. Langmuir (2013) 0.80
Dissipative curvature fluctuations in bilayer vesicles: Coexistence of pure-bending and hybrid curvature-compression modes. Eur Phys J E Soft Matter (2010) 0.80
Bioactive cell-like hybrids coassembled from (glyco)dendrimersomes with bacterial membranes. Proc Natl Acad Sci U S A (2016) 0.80
Highly robust crystalsome via directed polymer crystallization at curved liquid/liquid interface. Nat Commun (2016) 0.79
Morphology of nematic and smectic vesicles. Proc Natl Acad Sci U S A (2012) 0.79
Effects of Membrane Rheology on Leuko-polymersome Adhesion to Inflammatory Ligands. Soft Matter (2010) 0.79
Robust and responsive silk ionomer microcapsules. Biomacromolecules (2011) 0.79
Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet (2000) 24.22
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A (1999) 14.16
SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett (1995) 9.62
Lifetime of the P-selectin-carbohydrate bond and its response to tensile force in hydrodynamic flow. Nature (1995) 7.26
Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (1996) 5.44
Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science (1999) 4.08
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem (1998) 3.88
Interstitial cells of Cajal generate a rhythmic pacemaker current. Nat Med (1998) 3.62
Preparation of tubulin from brain. Methods Enzymol (1982) 3.39
The stabilization of proteins by sucrose. J Biol Chem (1981) 3.34
Rapid penicillinase paper strip test for detection of beta-lactamase-producing Haemophilus influenzae and Neisseria gonorrhoeae. Antimicrob Agents Chemother (1977) 3.02
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer (1999) 2.95
Adherence of Candida albicans and other Candida species to mucosal epithelial cells. Infect Immun (1980) 2.91
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
The association of cancer and the nephrotic syndrome. Ann Intern Med (1966) 2.88
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res (1999) 2.87
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther (1989) 2.78
The state diagram for cell adhesion under flow: leukocyte rolling and firm adhesion. Proc Natl Acad Sci U S A (2000) 2.76
Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet (1997) 2.69
The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J (1996) 2.64
Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther (1996) 2.63
The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain the type-specific genes flanked by common genes. Microbiology (1997) 2.61
Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell (1994) 2.60
Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase. J Biol Chem (1996) 2.55
Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother (2000) 2.48
Binding sites in Escherichia coli dihydrofolate reductase communicate by modulating the conformational ensemble. Proc Natl Acad Sci U S A (2000) 2.47
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology (1999) 2.40
Use of alternative techniques of hysterectomy in Ohio, 1988-1994. N Engl J Med (1996) 2.40
The forward rate of binding of surface-tethered reactants: effect of relative motion between two surfaces. Biophys J (1999) 2.35
Virulence of Staphylococcus aureus mutants altered in type 5 capsule production. Infect Immun (1991) 2.29
Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model. Infect Immun (1998) 2.29
Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem (1997) 2.28
Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line. J Immunol (1982) 2.22
Optimal matrix rigidity for stress fiber polarization in stem cells. Nat Phys (2010) 2.16
Cytolysis induced by human lymphotoxin. Am J Pathol (1972) 2.14
Multiparticle adhesive dynamics. Interactions between stably rolling cells. Biophys J (2001) 2.13
Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem (1998) 2.12
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J Immunol (2000) 2.11
Characterization of Candida albicans adherence to human vaginal epithelial cells in vitro. Infect Immun (1983) 2.07
Application of fluorescence energy transfer and polarization to monitor Escherichia coli cAMP receptor protein and lac promoter interaction. Proc Natl Acad Sci U S A (1990) 2.05
Partial specific volumes and interactions with solvent components of proteins in guanidine hydrochloride. Biochemistry (1974) 2.03
The reconstitution of microtubules from purified calf brain tubulin. Biochemistry (1975) 2.02
In vitro reconstitution of calf brain microtubules: effects of solution variables. Biochemistry (1977) 1.99
Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun (1997) 1.99
A new nomenclature for the cytoplasmic ribosomal proteins of Saccharomyces cerevisiae. Nucleic Acids Res (1997) 1.99
Sialyl Lewis(x)/E-selectin-mediated rolling in a cell-free system. Biophys J (1996) 1.96
The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem (1988) 1.95
Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation (1999) 1.93
A microcantilever device to assess the effect of force on the lifetime of selectin-carbohydrate bonds. Biophys J (2001) 1.88
Multiparticle adhesive dynamics: hydrodynamic recruitment of rolling leukocytes. Proc Natl Acad Sci U S A (2001) 1.86
Integration of synthetic globin genes into an E. coli plasmid. Nucleic Acids Res (1976) 1.85
Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res (1999) 1.82
Establishment of continuous cultures of thy1.2+, Lyt1+, 2-T cells with purified interleukin 3. Cell (1981) 1.80
The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun (1997) 1.80
Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun (1999) 1.80
Simulations of the erythrocyte cytoskeleton at large deformation. I. Microscopic models. Biophys J (1998) 1.75
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol (2000) 1.75
Quantifying rolling adhesion with a cell-free assay: E-selectin and its carbohydrate ligands. Biophys J (1997) 1.75
Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem (1996) 1.74
Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum (2000) 1.72
Development and characterization of a Staphylococcus aureus nasal colonization model in mice. Infect Immun (1999) 1.69
Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase. Infect Immun (2000) 1.68
Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect Immun (1992) 1.67
Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin. Biophys J (2000) 1.65
The chemical characterization of calf brain microtubule protein subunits. J Biol Chem (1973) 1.65
Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis. J Infect Dis (1992) 1.64
Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc Natl Acad Sci U S A (2001) 1.64
Deformation-enhanced fluctuations in the red cell skeleton with theoretical relations to elasticity, connectivity, and spectrin unfolding. Biophys J (2001) 1.64
Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol (1997) 1.64
Forced unfolding modulated by disulfide bonds in the Ig domains of a cell adhesion molecule. Proc Natl Acad Sci U S A (2001) 1.63
Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem (2000) 1.60
Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immun (2001) 1.59
Effectiveness of a continuous quality improvement program aiming to reduce unplanned extubation: a prospective study. Intensive Care Med (1996) 1.58
General analysis of receptor-mediated viral attachment to cell surfaces. Biophys J (1990) 1.58
Identification of ribosomal protein autoantigens. J Immunol (1985) 1.57
Dynamics of neutrophil rolling over stimulated endothelium in vitro. Biophys J (1994) 1.55
AA.AG@helix.ends: A:A and A:G base-pairs at the ends of 16 S and 23 S rRNA helices. J Mol Biol (2001) 1.54
Pelvic support defects and visceral and sexual function in women treated with sacrospinous ligament suspension and pelvic reconstruction. Am J Obstet Gynecol (1996) 1.54
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther (2001) 1.54
Laryngeal chemosensitivity: a possible mechanism for sudden infant death. Pediatrics (1975) 1.54
The effect of acute hypoxia and hypercapnia on the ultrastructure of the central nervous system. Brain (1968) 1.52
Preferential solvent interactions between proteins and polyethylene glycols. J Biol Chem (1981) 1.52
Adhesive dynamics simulations of sialyl-Lewis(x)/E-selectin-mediated rolling in a cell-free system. Biophys J (2000) 1.52
Polymer-polymer phase behavior. Science (1991) 1.52
Rapid diagnosis of gram-negative bacterial meningitis by the Limulus endotoxin assay. J Clin Microbiol (1978) 1.51
The fine structure, potassium content, and respiratory activity of isolated rat liver parenchymal cells prepared by improved enzymatic techniques. J Cell Biol (1973) 1.49
A theoretical analysis for the effect of focal contact formation on cell-substrate attachment strength. Biophys J (1993) 1.49
Extracellular matrix elasticity directs stem cell differentiation. J Musculoskelet Neuronal Interact (2007) 1.47
Characterization of Glu126 and Arg144, two residues that are indispensable for substrate binding in the lactose permease of Escherichia coli. Biochemistry (1999) 1.47
Molecular genetic analysis of non-astrocytic gliomas. Histopathology (1999) 1.45
Receptor-mediated binding of IgE-sensitized rat basophilic leukemia cells to antigen-coated substrates under hydrodynamic flow. Biophys J (1994) 1.45
Acute diffuse glomerulonephritis in acute staphylococcal endocarditis. Ann Intern Med (1969) 1.45
Interstitial nephritis in Sjögren's syndrome. Ann Intern Med (1968) 1.44
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev (2001) 1.43
Escherichia coli cAMP receptor protein: evidence for three protein conformational states with different promoter binding affinities. Biochemistry (1989) 1.43
p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun (1997) 1.42
Cell-free rolling mediated by L-selectin and sialyl Lewis(x) reveals the shear threshold effect. Biophys J (2000) 1.42